Mangoceuticals (MGRX) Competitors $1.69 +0.03 (+1.81%) As of 03:24 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MGRX vs. MRAI, CCM, BRTX, BGLC, SSY, ACON, ATIP, DHAC, NIVF, and OTRKShould you be buying Mangoceuticals stock or one of its competitors? The main competitors of Mangoceuticals include Marpai (MRAI), Concord Medical Services (CCM), Biorestorative Therapies (BRTX), BioNexus Gene Lab (BGLC), SunLink Health Systems (SSY), Aclarion (ACON), ATI Physical Therapy (ATIP), Digital Health Acquisition (DHAC), NewGenIvf Group (NIVF), and Ontrak (OTRK). These companies are all part of the "healthcare" industry. Mangoceuticals vs. Its Competitors Marpai Concord Medical Services Biorestorative Therapies BioNexus Gene Lab SunLink Health Systems Aclarion ATI Physical Therapy Digital Health Acquisition NewGenIvf Group Ontrak Marpai (NASDAQ:MRAI) and Mangoceuticals (NASDAQ:MGRX) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment. Which has better earnings and valuation, MRAI or MGRX? Mangoceuticals has lower revenue, but higher earnings than Marpai. Marpai is trading at a lower price-to-earnings ratio than Mangoceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMarpai$34.87M0.66-$28.75M-$0.87-1.53Mangoceuticals$620K13.47-$8.71M-$3.86-0.42 Which has more risk & volatility, MRAI or MGRX? Marpai has a beta of 4.66, suggesting that its stock price is 366% more volatile than the S&P 500. Comparatively, Mangoceuticals has a beta of 2.42, suggesting that its stock price is 142% more volatile than the S&P 500. Is MRAI or MGRX more profitable? Marpai has a net margin of -85.70% compared to Mangoceuticals' net margin of -2,757.86%. Marpai's return on equity of 0.00% beat Mangoceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Marpai-85.70% N/A -100.23% Mangoceuticals -2,757.86%-85.01%-78.08% Do institutionals & insiders have more ownership in MRAI or MGRX? 49.8% of Marpai shares are owned by institutional investors. Comparatively, 56.7% of Mangoceuticals shares are owned by institutional investors. 46.1% of Marpai shares are owned by company insiders. Comparatively, 16.0% of Mangoceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the media prefer MRAI or MGRX? In the previous week, Mangoceuticals had 2 more articles in the media than Marpai. MarketBeat recorded 2 mentions for Mangoceuticals and 0 mentions for Marpai. Marpai's average media sentiment score of 1.05 beat Mangoceuticals' score of -0.76 indicating that Marpai is being referred to more favorably in the media. Company Overall Sentiment Marpai Positive Mangoceuticals Negative SummaryMarpai beats Mangoceuticals on 7 of the 13 factors compared between the two stocks. Get Mangoceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MGRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MGRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MGRX vs. The Competition Export to ExcelMetricMangoceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.35M$2.81B$5.81B$9.75BDividend YieldN/A1.66%3.84%4.09%P/E Ratio-0.4222.8230.8925.96Price / Sales13.47764.02469.53120.82Price / CashN/A173.2237.1558.38Price / Book0.435.849.116.37Net Income-$8.71M$31.83M$3.26B$265.56M7 Day Performance-1.52%1.75%1.82%1.79%1 Month Performance-0.92%4.39%4.81%1.13%1 Year Performance-97.52%11.43%31.07%21.04% Mangoceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MGRXMangoceuticals0.4471 of 5 stars$1.69+1.8%N/A-97.4%$8.74M$620K-0.443News CoverageShort Interest ↑MRAIMarpaiN/A$1.45+2.1%N/A+206.6%$25.04M$34.87M-0.55150Positive NewsGap DownCCMConcord Medical Services0.5186 of 5 stars$5.44+2.3%N/A-25.8%$23.08M$52.60M0.00970Negative NewsBRTXBiorestorative Therapies2.5086 of 5 stars$1.51-2.3%N/A-10.6%$12.29M$400K-1.197BGLCBioNexus Gene Lab0.03 of 5 stars$5.32flatN/A+31.9%$9.56M$9.51M0.0030Negative NewsEarnings ReportSSYSunLink Health Systems2.2141 of 5 stars$1.12+16.6%N/A+37.3%$7.88M$31.09M4.661,376Gap UpACONAclarion1.5878 of 5 stars$7.02-3.6%$11,758.50+167,400.0%-99.6%$4.24M$50K0.007Gap DownHigh Trading VolumeATIPATI Physical TherapyN/A$0.68flatN/A-88.6%$2.98M$741.86M-0.045,600DHACDigital Health AcquisitionN/A$0.81+3.6%N/A-55.7%$2.92MN/A0.002,021News CoverageGap UpNIVFNewGenIvf GroupN/A$1.83-4.2%N/A-99.8%$1.65M$5.43M0.00N/APositive NewsOTRKOntrak2.1817 of 5 stars$0.10-68.8%$3.00+2,900.0%-98.2%$1.35M$10.18M-0.01250Negative News Related Companies and Tools Related Companies MRAI Alternatives CCM Alternatives BRTX Alternatives BGLC Alternatives SSY Alternatives ACON Alternatives ATIP Alternatives DHAC Alternatives NIVF Alternatives OTRK Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MGRX) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersSilver’s Still Under $35… For Now.Silver is trading around $33—but insiders are betting on a $70 breakout by year’s end. With supply shrinkin...GoldenCrest Metals | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mangoceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mangoceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.